Study of the central mechanism of dexmedetomidine: based on resting state fMRI

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR1900023444

Enrollment

Unknown

Registered

2019-05-27

Start date

2019-06-08

Completion date

Unknown

Last updated

2019-06-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Changes of brain function

Interventions

1:Intravenous infusion of dexmedetomidine

Eligibility

Sex/Gender

All

Age

18 Years to 40 Years

Inclusion criteria

Inclusion criteria: healthy volunteers, right handedness, aged 18-40 years.

Exclusion criteria

Exclusion criteria: be complicated with cardiovascular and cerebrovascular diseases, mental illness,tumour, severe systemic diseases; have history of dexmedetomidine allergy, history of head trauma, claustrophobia, metal implants in vivo; obesity, thicker tattooed eyebrows, dyed the hair in two weeks; during pregnancy preparation period, gestational period or suckling period.

Design outcomes

Primary

Measure	Time frame
Amplitude of Low Frequency Fluctuations,ALFF;Independent Component Analysis,ICA;brain network;	—

Countries

China

Contacts

Public ContactTianzuo Li

Peking University Hospital of Stomatology

trmzltz@126.com+86 13911072068

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026